Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05084976 · ClinicalTrials.gov registry record
Parental Perception of COVID-19 Vaccine in Technology Dependent Patients
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 60
- Enrollment target
NCT05084976: Completed study, sponsored by Northwell Health.
NCT05084976 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05084976 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This study involves conducting a telephonic or in person survey regarding parental perception and attitudes about vaccinating the respective "technology dependent" child with the COVID 19 vaccination. "Technology dependent" includes tracheostomy dependence, artificial ventilator dependence and non invasive mechanical ventilation dependence. This population is vulnerable since most patients have underlying lung disease, chronic respiratory failure and require respiratory equipment to assist with breathing. "Technology dependent" patients are particularly vulnerable to respiratory infections and are considered high risk for developing severe COVID 19 illness. Despite this population's high risk for morbidity and mortality from respiratory viral infections, the investigator hypothesize that 50% of the parents are still vaccine hesitant.
Interventions
- BEHAVIORAL COVID 19 vaccine counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-09-23 |
| Est. Completion | 2022-03-31 |
What the finished NCT05084976 record still lists
NCT05084976 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which COVID 19 vaccine counseling is the first listed.
NCT05084976 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05084976 about?
NCT05084976 is a clinical study titled "Parental Perception of COVID-19 Vaccine in Technology Dependent Patients". This study involves conducting a telephonic or in person survey regarding parental perception and attitudes about vaccinating the respective "technology dependent" child with the COVID 19 vaccination. "Technology dependent" includes tracheostomy dependence, artificial ventilator dependence and non i...
What is the current status of trial NCT05084976?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2021-09-23. Estimated completion is 2022-03-31.
What interventions are being tested in trial NCT05084976?
The interventions under investigation include: COVID 19 vaccine counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT05084976?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI